XNK Therapeutics to present at ABG Sundal Collier’s Life Science Summit in Stockholm
XNK Therapeutics today announced that its CEO Johan Liwing will present at ABG Sundal Collier’s Life Science Summit in Stockholm, Sweden, on May 31 at 10:00am CEST.The presentation is followed by a short Q&A session, moderated by an ABGSC analyst, and a recording will be available after the event. For more information, please contact: Johan Liwing, CEO, XNK Therapeutics Tel: +46 706 70 36 75 E-mail: johan.liwing@xnktherapeutics.com About XNK Therapeutics AB XNK Therapeutics is a clinical stage, immunotherapy company focusing its efforts on preventing and treating cancer by